Pfizer begins early-stage study for oral COVID-19 drug

WASHINGTON: Pfizer has started an early-stage trial of an oral COVID-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said. The drugmaker, which developed the first authorized COVID-19 vaccine in the US